Cardinal Resources Ltd. Stock
€0.67
Your prediction
Financial data and news for Cardinal
sharewise wants to provide you with the best news and tools for Cardinal, so we directly link to the best financial data sources.
Financials
News
Cardinal Health Q4 Earnings Call Highlights
Key Points
- Interested in Cardinal Health, Inc.? Here are five stocks we like better.
- Cardinal Health delivered strong fiscal fourth-quarter results: Revenue rose 6% to $63.7 billion, operating
Cardinal Infrastructure Group Q2 Earnings Call Highlights
Key Points
- Interested in Cardinal Infrastructure Group Inc.? Here are five stocks we like better.
- Record growth lifted the outlook: Second-quarter revenue surged 114% year over year to $227
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth
Key Points
- Interested in AdaptHealth Corp.? Here are five stocks we like better.
- AdaptHealth is selling its roughly $600 million diabetes business to Cardinal Health and exiting certain
Matador Resources Q2 Earnings Call Highlights
Key Points
- Interested in Matador Resources Company? Here are five stocks we like better.
- Strong second-quarter cash generation supported deleveraging: Matador Resources produced $303 million
Amazon.com Q2 Earnings Call Highlights
Key Points
- Interested in Amazon.com, Inc.? Here are five stocks we like better.
- Amazon delivered strong second-quarter results: Revenue rose 20% year over year to $200.6 billion, while operating
Cardinal Infrastructure Group Q1 Earnings Call Highlights
Cardinal Infrastructure Group (NASDAQ:CDNL) reported sharp first-quarter growth and raised its full-year revenue outlook, citing record backlog, strong organic demand and early contributions from
Clearway Energy Q1 Earnings Call Highlights
Clearway Energy (NYSE:CWEN) reaffirmed its 2026 financial guidance and said it now has greater visibility into growth investments through the
Why Cardinal Infrastructure Group Stock Just Crashed
Cardinal Infrastructure Group (NASDAQ: CDNL) stock is getting crushed in Tuesday's trading. Shares were down 25.7% as of 11:30 a.m. ET despite relatively little movement for the broader market.
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
Can high-flying growth justify a premium valuation, or is a recovered value play the safer bet for 2026? Investors are weighing Eli Lilly and (NYSE:LLY) against Teva Pharmaceutical Industries (NYSE:
2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now
Shares of Cencora (NYSE: COR) and Stevanato Group (NYSE: STVN) are down more than 17% and 5%, respectively, so far this year. This is despite solid first-quarter earnings and steady business models.